Turn Therapeutics Earnings
NASDAQ: TTRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.10-0.545 (-6.31%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Turn Therapeutics earnings summary
In its most recent report on Nov 12, 2026 (Sep/2026), TTRX posted EPS of $-0.21. Quarterly EPS is down 2200.0% from the same quarter a year earlier. Across the last 6 reports, TTRX shares moved an average of 12.1% (in either direction) in the first trading session after results, rising 1 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
TTRX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 12, 2026 | — | $-0.21 | — | -13.4% |
| Nov 9, 2026 | — | $-0.21 | — | -13.4% |
| Aug 12, 2026 | — | $-0.20 | — | -1.1% |
| May 11, 2026 | — | $-0.03 | — | +26.7% |
| Mar 31, 2026 | — | $0.01 | — | 0.0% |
| Nov 13, 2025 | — | $-0.07 | — | -18.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.